Brief: Phasebio Pharmaceuticals Reports Fourth Quarter And Full-Year 2021 Financial Results And Provides Recent Business Highlights
24/03/2022 20:34
March 24 (Reuters) - PhaseBio Pharmaceuticals Inc PHAS.O :
* PHASEBIO PHARMACEUTICALS REPORTS FOURTH QUARTER AND
FULL-YEAR
2021 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS HIGHLIGHTS
* PHASEBIO PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.90
Source text for Eikon: ID:nBw1ZMrcKa
Further company coverage: PHAS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PhaseBio Pharmaceuticals
See all newsBrief: Phasebio Pharmaceuticals Says Bankruptcy Court Entered Order Approving 1st Amended Combined Disclosure Statement & Chapter 11 Plan On Final Basis
U.S. RESEARCH ROUNDUP- Entegris, FedEx, Kellogg
U.S. RESEARCH ROUNDUP- Armstrong World Industries, Eli Lilly, Netflix
U.S. STOCKS ON THE MOVE-TransDigm, Vaxcyte, Tricida
PhaseBio Pharma slips on bankruptcy plans